Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice.
Study Design
- Tipo de estudio
- Other
- Población
- men
- Intervención
- Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice. 80 mg/kg
- Comparador
- None
- Resultado primario
- None
- Dirección del efecto
- Mixed
- Riesgo de sesgo
- Unclear
Abstract
Zinc is an essential trace element for humans and animals, being located, among other places, in the synaptic vesicles of cortical glutamatergic neurons and hippocampal mossy fibers in the brain. Extracellular zinc has the potential to interact with and modulate many different synaptic targets, including glutamate and GABA receptors. Because of the central role of these neurotransmitters in brain activity, we examined in this study the sleep-promoting activity of zinc by monitoring locomotor activity and electroencephalogram after its administration to mice. Zinc-containing yeast extract (40 and 80 mg/kg) dose dependently increased the total amount of nonrapid eye movement sleep and decreased the locomotor activity. However, this preparation did not change the amount of rapid eye movement sleep or show any adverse effects such as rebound of insomnia during a period of 24 h following the induction of sleep; whereas the extracts containing other divalent cations (manganese, iron, and copper) did not decrease the locomotor activity. This is the first evidence that zinc can induce sleep. Our data open the way to new types of food supplements designed to improve sleep.
TL;DR
This work examines the sleep-promoting activity of zinc by monitoring locomotor activity and electroencephalogram after its administration to mice and finds the first evidence that zinc can induce sleep.
Used In Evidence Reviews
Similar Papers
Pflugers Archiv : European journal of physiology · 2010
Glutamate receptors, neurotoxicity and neurodegeneration.
Pharmacological research · 1999
Health benefits of docosahexaenoic acid (DHA).
Circulation · 2010
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
Contemporary clinical trials · 2012
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
Oxidative medicine and cellular longevity · 2013
Cadmium and its neurotoxic effects.
Journal of clinical hypertension (Greenwich, Conn.) · 2011